Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 15Prostatic Neoplasms 9Colorectal Neoplasms 7Ovarian Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Brain Neoplasms 3Urogenital Neoplasms 2Neoplastic Syndromes, Hereditary 2Neoplasms, Unknown Primary 2Neoplasm Metastasis 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Hereditary Breast and Ovarian Cancer Syndrome 2Hematologic Neoplasms 2Glioma 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Tuberous Sclerosis 1Thyroid Neoplasms 1Spinal Cord Neoplasms 1

Interventions

Genetic Testing 1Biological Oxygen Demand Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lipodystrophy, Familial Partial × Genetic Testing × Clear all
NCT07412028 2026-02-17

ANDROLIPO

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting
81 enrolled

Polycystic Ovary Syndrome, Lipodystrophy, Familial Partial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡